Hematologic Gene Editing and Gene Therapies
Hematologic gene editing and gene therapies are innovative approaches aimed at treating various blood disorders and hematologic diseases by modifying or correcting the genetic components involved.
- CRISPR-Cas9 and other gene-editing technologies in hematology.
- Clinical trials and breakthroughs in gene therapy for blood disorders.
- Ethical considerations in genetic modification for hematologic diseases.
Related Conference of Hematologic Gene Editing and Gene Therapies
Hematologic Gene Editing and Gene Therapies Conference Speakers
Recommended Sessions
- Bleeding Disorders in Women
- Digital Health and Artificial Intelligence (AI) in Hematology
- Hematologic Gene Editing and Gene Therapies
- Hematology and Stem Cell Research
- Hematopoietic Stem Cell Transplantation
- Hemoglobinopathies and Sickle Cell Disease
- Hemophilia Management and Research
- Hemostasis and Thrombosis
- Immunotherapy and Hematology
- Leukemia and Lymphoma
- Medicine in Hematology
- Molecular Hematology
- Myelodysplastic Syndromes (MDS) and Bone Marrow Failure
- Next-Generation Diagnostics and Imaging
- Novel Therapies for Blood Cancers
- Pediatric Hematology
- Platelet Disorders
- Sickle Cell Disease (SCD)
- Thalassemia Management
- Transfusion Medicine and Blood Banking